We also found frequent co-occurrences of CSF3R mutations with alterations involving other genes including, but not limited to, ASXL1, NRAS, KRAS, and SETBP1 in the MDS/MPN-U and CMML patients. This evidence concerns the gene KRAS and myeloproliferative neoplasm, unclassifiable.